• An Emerging Treatment for Metastatic Prostate Cancer

    A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.

    by Pamela Rafalow Grossman

  • Drug Delays Recurrence in People With Early-Stage Breast Cancer

    People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.

    by Pamela Rafalow Grossman

  • Remote Care

    After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.

    by Jon Kelvey

  • Moving Away From the Maximum Tolerated Dose

    The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.

    by Marcus A. Banks

  • From the Editor-in-Chief

    The Tumor Microenvironment

    Research is leading to treatments that target cancer’s support system.

    by William G. Nelson, MD, PhD 

  • Forward Look

    First CAR-T Cell Therapy Approved for Multiple Myeloma

    Cellular immunotherapies can offer periods when people do not require treatment.

    by Christina Bennett

  • Forward Look

    Going Flat

    Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.

    by Kris Conner

  • Forward Look

    The Impact of HPV Vaccination

    Over a decade after human papillomavirus vaccines first became available in the U.S., their effect on cervical cancer incidence is becoming apparent.

    by Carisa D. Brewster

  • Forward Look

    What’s Next?

    Using fecal transplants to improve immunotherapy response

    by Natalie Slivinski

  • Are You a Candidate for Immunotherapy?

    Tumor testing can help determine whether certain cancers are likely to respond to immunotherapy drugs.

    by Kendall K. Morgan


From the AACR



Learning Medicare’s ABCDs


social media

donate to the AACR